Article
Pharmaceutical R&D And IP Commercialisation Gain Momentum In Ghana
Eight Ghanaian research-industry partnerships have been awarded €2 million in grants to advance vaccine and pharmaceutical R&D, including malaria treatments and AI-assisted antibody discovery. The PharmaVax Ghana programme aims to translate research into locally manufactured health products, with IP protection and technology transfer playing key roles in commercializing innovations for Ghana and regional markets.
Adams & Adams